HomeALPMY • OTCMKTS
add
Astellas Pharma ADR Representing 1 Ord Shs
Nakaraang pagsara
$10.71
Sakop ng araw
$10.57 - $10.62
Sakop ng taon
$8.37 - $12.45
Market cap
2.96T JPY
Average na Volume
129.62K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 505.79B | 6.91% |
Gastos sa pagpapatakbo | 306.92B | -6.62% |
Net na kita | 68.42B | 81.96% |
Net profit margin | 13.53 | 70.19% |
Kita sa bawat share | — | — |
EBITDA | 151.84B | 46.59% |
Aktuwal na % ng binabayarang buwis | 24.33% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 215.40B | -28.89% |
Kabuuang asset | 3.34T | -10.70% |
Kabuuang sagutin | 1.85T | -9.96% |
Kabuuang equity | 1.48T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 0.01 | — |
Return on assets | 7.79% | — |
Return on capital | 11.03% | — |
Cash Flow
Net change in cash
| (JPY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 68.42B | 81.96% |
Cash mula sa mga operasyon | 54.84B | 335.21% |
Cash mula sa pag-invest | -16.74B | 57.44% |
Cash mula sa financing | -11.04B | 7.36% |
Net change in cash | 27.03B | 182.50% |
Malayang cash flow | 9.85B | 191.42% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
13,643
